Novel Antiretroviral Drugs for HIV/AIDS

Current antiretroviral drugs for human immunodeficiency virus infection: review article

Currently, there are about 37 million people worldwide living with human immunodeficiency virus (HIV) /AIDS, with an estimated two million new cases per year globally. According to estimates from the World Health Organization (WHO), only 75% of the population with HIV know their status. Initially, HIV infection was associated with significantly increased rates of mortality and morbidity. Howeve...

[Pharmacogenetics of antiretroviral drugs].

Clinical Guidelines: Antiretroviral Drugs for Hiv Prevention

Novel drugs--novel branding.

There has been increasing use of a number of different novel psychoactive substances (often referred to as ‘legal highs’) over the last few years. The drug that has received the most publicity is mephedrone. However, there were 41 new substances detected in Europe in 2010. These novel psychoactive substances are often purchased from Internet-based suppliers and are commonly marketed under broad...

Interactions between recreational drugs and antiretroviral agents.

OBJECTIVE To summarize existing data regarding potential interactions between recreational drugs and drugs commonly used in the management of HIV-positive patients. DATA SOURCES Information was obtained via a MEDLINE search (1966-August 2002) using the MeSH headings human immunodeficiency virus, drug interactions, cytochrome P450, medication names commonly prescribed for the management of HIV...